6 hrs ago | WBT-AM Charlotte
"Extreme Makeover" Gives N.C. Family New Home
Having practiced it with gusto, several thousand onlookers were excited when the time came Tuesday to welcome Tricia Creasey and her family to their new home.
Yesterday | MediLexicon
Merck KGaA: CHMP Opinion For Erbitux In Advanced Non-Small Cell Lung Cancer
The Committee for Medicinal Products for Human Use , the scientific committee of the European Medicines Agency , has adopted a negative opinion for the use of Erbitux in combination with platinum-based chemotherapy for the treatment of patients with epidermal growth factor receptor -expressing, advanced or metastatic non-small cell lung cancer .
Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?
JHRRNMS Abstract BACKGROUND:The development of novel chemotherapeutic agents in colorectal cancer has improved survival.
Guidelines for cancer screening differ by group
Several doctors groups and advocacy groups set guidelines for cancer screening, and they update that advice periodically as new information emerges.
Poniard Pharmaceuticals Announces Updated Positive Clinical Data From ...
Main Category: Colorectal Cancer Also Included In: Cardiovascular / Cardiology ; Clinical Trials / Drug Trials ; Pharma Industry / Biotech Industry Article Date: 18 Nov 2009 - 2:00 PST Poniard Pharmaceuticals, Inc.
Data on Synta Pharmaceuticals' STA-9090 synthetic inhibitor of Hsp90 presented
Synta Pharmaceuticals Corp. , a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical data presented at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics shows that STA-9090, a novel, synthetic inhibitor of ...
Clinical Trials Update: Nov. 18, 2009
Here are the latest clinical trials, courtesy of ClinicalConnection.com : Metastatic Colorectal Cancer This study is for people with colorectal cancer that has metastasized .
Poniard rebounds on picoplatin colon cancer data
A day after Poniard Pharmaceuticals Inc. said its drug candidate picoplatin failed to improve survival for patients with lung cancer, the company reported positive data on the drug as a treatment for colorectal cancer.
Cequent Files Its First IND With FDA: CEQ508, A TkRNAi Drug Candidate In Oncology
Main Category: Cancer / Oncology Also Included In: Pharma Industry / Biotech Industry Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, has announced that it has filed its first IND application with the U.S. Food and Drug Administration .
Sudden Cardiac Death Much More Likely to Strike Men
Men, especially black men, are at a relatively high risk of sudden cardiac death over their lifetime compared to women, a new study finds.
Paradoxical Protein Might Prevent Cancer
Main Category: Colorectal Cancer Also Included In: Biology / Biochemistry Article Date: 14 Nov 2009 - 1:00 PST One difficulty with fighting cancer cells is that they are similar in many respects to the body's stem cells .
Tapping Into Curry's Health Benefits
Tiny capsules could increase the body's absorption of the yellow curry ingredient curcumin, which is being tested in clinical trials for the treatment of colon cancer, psoriasis and Alzheimer's disease.
'Cross-talk' Mechanism Contributes To Colorectal Cancer
Researchers at the University of Wisconsin-Madison School of Medicine and Public Health have identified a molecular mechanism that allows two powerful signaling pathways to interact and begin a process leading to colorectal tumors.
African-Americans with colorectal cancer have poorer outcomes, lower survival rates
New research published in the November issue of the Journal of the American College of Surgeons shows that African-American patients with colorectal cancer are more likely to be diagnosed with advanced disease and are less likely to undergo surgical procedures compared with Caucasians, suggesting that improvements in screening and rates of ...
Cassidy: Silicon Valley inventor seeks next big thing in cancer fight
Silicon Valley entrepreneur and inventor Robert Goldman in the office of his San Jose home on Tuesday, Nov.
Cequent Pharmaceuticals proposes the first test of an orally...
Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, has announced that it has filed its first IND application with the U.S. Food and Drug Administration .
Coffee break: Compound brewing new research in colon, breast cancer
" A compound in coffee has been found to be estrogenic in studies by Texas AgriLife Research scientists.
Paul Donohue: Hemorrhoids have many treatments
Dear Dr. Donohue: What kind of doctor removes hemorrhoids? Mine are very irritating.
New Polyp Detection Method Could Be Cost-Saver
Optical technology could help physicians detect small colorectal polyps during colonoscopies and save money, too, new research suggests.
Cancer is the general name for over 100 medical conditions involving uncontrolled and dangerous cell growth.
Also on Topix